Efficacy and safety of ipragliflozin as an add‐on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial

AIM: To evaluate the efficacy and safety of ipragliflozin vs placebo as add‐on therapy to metformin and sitagliptin in Korean patients with type 2 diabetes mellitus (T2DM). METHODS: This double‐blind, placebo‐controlled, multi‐centre, phase III study was conducted in Korea in 2015 to 2017. Patients...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Obes Metab
Autors principals: Han, Kyung‐Ah, Chon, Suk, Chung, Choon Hee, Lim, Soo, Lee, Kwan‐Woo, Baik, SeiHyun, Jung, Chang Hee, Kim, Dong‐Sun, Park, Kyong Soo, Yoon, Kun‐Ho, Lee, In‐Kyu, Cha, Bong‐Soo, Sakatani, Taishi, Park, Sumi, Lee, Moon‐Kyu
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6175352/
https://ncbi.nlm.nih.gov/pubmed/29862619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13394
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars